Processa Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Processa Pharmaceuticals, Inc. on August 25, 2025. The report addresses administrative changes regarding the company's 2025 Special Meeting of Stockholders, originally scheduled to be held at the company's principal executive offices in Vero Beach, Florida.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
- Meeting Location Change: On August 25, 2025, the Board of Directors changed the location of the Special Meeting of Stockholders from 601 21st Street, Suite 300, Vero Beach, FL 32960, to 594 East Colorado Blvd. Suite 200, Pasadena, CA 91101.
- Proxy Statement Reference: The change relates to the proxy statement filed on August 13, 2025, pursuant to Section 14(a) of the Securities Exchange Act of 1934.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the logistical update of the stockholder meeting venue.
Key Facts for Investor Verification
- Verify the new meeting location: 594 East Colorado Blvd. Suite 200, Pasadena, CA 91101.
- Confirm the date of the Special Meeting of Stockholders by reviewing the original Proxy Statement filed on August 13, 2025.
- Note that no financial performance data is included in this specific filing.